[
    "{\"step_by_step_thinking\": \"Belimumab is a monoclonal antibody used in the treatment of systemic lupus erythematosus (SLE). According to the documents, belimumab has shown efficacy in improving renal outcomes in patients with lupus nephritis, a common and severe manifestation of SLE. Document [1] states that belimumab was found to be effective in improving kidney response in patients with lupus nephritis. Document [4] also supports this, stating that belimumab showed an improvement in renal parameters in patients with lupus nephritis. Document [6] further supports this by stating that belimumab was instrumental for beneficial renal response in patients with lupus nephritis. Therefore, based on these documents, it can be concluded that belimumab is effective for lupus nephritis.\", \"answer_choice\": \"A\"}"
]